PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
33032082-7	2021	These novel DMPs were found to set off the release of higher levels of tumour necrosis factor alpha (TNF-alpha) than Murabutide, which is a well-known NOD2 agonist.	murabutide	117-127	nucleotide binding oligomerization domain containing 2	Homo sapiens	151-155	
22855691-1	2012	Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) receptor on mammalian cells.	murabutide	0-10	nucleotide binding oligomerization domain containing 2	Homo sapiens	65-127	
22855691-1	2012	Murabutide (MB) is a synthetic immunomodulator recognized by the nucleotide-binding oligomerization domain-containing protein 2 (NOD2) receptor on mammalian cells.	murabutide	0-10	nucleotide binding oligomerization domain containing 2	Homo sapiens	129-133	
29028529-5	2017	Furthermore, these compounds were able to trigger the secretion of higher levels of pro-inflammatory cytokine (TNF-alpha) than the well-studied NOD2 agonist, Murabutide.	murabutide	158-168	nucleotide binding oligomerization domain containing 2	Homo sapiens	144-148	
23531213-4	2013	Murabutide is a safe derivative of MDP, which interacts with cells of the immune system, both innate and adaptive, and exerts its effect through activation of Nod2.	murabutide	0-10	nucleotide binding oligomerization domain containing 2	Homo sapiens	159-163